MIRA
INFORM REPORT
|
Report Date : |
18.08.2012 |
IDENTIFICATION DETAILS
|
Name : |
EUROFARMA LABORATORIOS SA |
|
|
|
|
Registered Office : |
Avenida Vereador Jose Diniz, 3465 - Campo Belo , Zip Code 04603-003 - São Paulo/Sp |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
27.06.1962 |
|
|
|
|
Legal Form : |
Privately Held Corporation |
|
|
|
|
Line of Business : |
Manufacture of pharmaceutical products |
|
|
|
|
No. of Employees : |
3500 Employees |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Good |
|
Payment Behaviour : |
Regular |
|
Litigation : |
Exists |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name
EUROFARMA
LABORATORIOS S/A
company ADDRESSES
|
MAIN ADDRESS: |
AVENIDA VEREADOR JOSE DINIZ, 3465 - CAMPO BELO |
|
ZIP CODE/CITY: |
04603-003 - SÃO PAULO/SP |
|
|
|
|
PHONE: |
11 5090-8552 |
|
FAX: |
11 5090-8552 |
|
E-MAIL: |
|
|
WEB SITE: |
|
BRANCHES: |
|
|
|
|
|
ADDRESS: |
AVENIDA DAS NAÇÕES UNIDAS, 22532 - SANTO AMARO |
|
ZIP CODE/CITY: |
04795-100 SÃO PAULO/SP |
|
CNPJ: |
61.190.096/0004-35 |
|
|
|
|
ADDRESS: |
RUA ENÉAS LUIS CARLOS BARBANTI, 216 - FREGUESIA DO Ó |
|
ZIP CODE/CITY: |
02911-000 SÃO PAULO/SP |
|
CNPJ: |
61.190.096/0005-16 |
|
|
|
|
ADDRESS: |
RUA VIÚVA CLÁUDIO, 144 150, 152 E 160 - JACARÉ |
|
ZIP CODE/CITY: |
RIO DE JANEIRO/RJ |
|
CNPJ: |
61.190.096/0003-54 |
|
|
|
|
ADDRESS: |
ESTRADA VINHEDO VIRACOPOS, KM 4 S/Nº - DISTRITO INDUSTRIAL |
|
ZIP CODE/CITY: |
13280-000 VINHEDO/SP |
|
CNPJ: |
61.190.096/0006-05 |
|
|
|
|
ADDRESS: |
AVENIDA PRESIDENTE CASTELO BRANCO, 1385 - PARQUE INDUSTRIAL LAGOINHA |
|
ZIP CODE/CITY: |
14095-000 RIBEIRÃO PRETO/SP |
|
PHONE: |
16 3512-4921 |
|
CNPJ: |
61.190.096/0011-64 |
|
|
|
|
ADDRESS: |
ALAMEDA DR. CARLOS DE CARVALHO, 417 CJ. 2103 - CENTRO |
|
ZIP CODE/CITY: |
80410180 CURITIBA/PR |
|
CNPJ: |
61.190.096/0009-40 |
|
FURTHER TO THE ABOVE THE COMPANY ALSO HAS OTHER BRANCHES LOCATED IN
ITAPEVI/SP, SÃO PAULO/SP, VINHEDO/SP, RIBEIRÃO PRETO/SP. |
LEGAL DATA
|
MAIN ACTIVITIES: |
|
MANUFACTURE OF PHARMACEUTICAL PRODUCTS. |
|
LEGAL FORM: |
PRIVATELY
HELD CORPORATION |
|
|
|
|
INCORPORATION DATE: |
27/06/1962 |
|
REGISTER DATE: |
27/06/1962 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
61.190.096/0001-92 |
|
STATE REGISTER: |
104.636.300.110 |
|
|
|
|
SHARE CAPITAL: |
R$ 531.867.763,00 |
|
BOARD OF
DIRECTORS: |
|
|
|
|
|
MAURIZIO BILLI |
PRESIDENT DIRECTOR |
|
GALLIANO BILLI |
SUPERVISING DIRECTOR |
|
MARIA TERESA CASELLI BILLI |
DIRECTOR |
AUTHORIZED USE OF SIGNATURE
|
THE DIRECTORS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
MAURIZIO BILLI |
60% |
|
GALLIANO BILLI |
20% |
|
MARIA TERESA CASELLI BILLI |
20% |
|
AFFILIATES /
SUBSIDIARIES: |
|
|
|
|
|
MAGABI INCORPORAÇÃO E EMPREEND. IMOBILIÁRIOS LTDA |
99,90% |
|
BILLI FARMACÊUTICA LTDA |
80% |
|
EUROFARMA DISTRIBUIDORA LTDA |
93,20% |
|
ISA LABORATORIOS LTDA. |
100,00% |
|
EUROGLASS, BRASILEIRA DE EMBALAGENS LTDA |
93,90% |
|
EUROFARMA - EDOL PRODUTOS FARMACÊUTICOS LTDA |
|
|
INCREMENTHA P, D & I PESQUISAS, DES. INOV. DE FARMACOS E MED |
50,00% |
|
INSTITUTO EUROFARMA |
|
|
MAGABI PESQUISAS CLÍNICAS E FARMACÊUTICAS |
|
|
INOVA BIOTECNOLOGIA SAÚDE ANIMAL LTDA |
50,00% |
|
EDOL - THEMAXIS (PORTUGAL) |
|
|
THEMAXIS S DE RL DE CV (MEXICO) |
|
|
THEMAXIS SRL (VENEZUELA) |
|
|
THEMAXIS LIMITADA (COLOMBIA) |
|
|
EUROFARMA COMERCIAL E IMPORTADORA LTDA |
100,00% |
|
M + 2 PARTICIPAÇÕES LTDA |
|
COMPANY'S BACKGROUND
|
THE SUBJECT WAS ESTABLISHED ON JUNE 27, 1962. FORMERLY IT OPERATED
WITH THE REGISTERED NAME INAF LABORATÓRIOS LTDA. THE DATE WHEN IT ADOPTED THE
CURRENT REGISTERED NAME WAS NOT PROVIDED. ON AUGUST 05, 2011 IT ALTERED TO
ABOVE-MENTIONED NAME AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL
SCENE REPORTED HEREIN. THE SUBJECT BELONGS TO BILLI GROUP WHICH IS ALSO OWNER OF THE
COMPANIES EUROGLASS AND STANLAR PRODUTOS PARA O LAR LTDA. IN 2001 THE SUBJECT TOOK OVER THE COMPANY PEARSON SAÚDE ANIMAL LTDA.,
WHICH BECAME A DIVISION. IN DECEMBER 2002 THE COMPANY BILLI FARMACÊUTICA LTDA. WAS TAKEN OVER
BY EUROFARMA LABORATÓRIOS LTDA. IN JUNE 2006 THE SUBJECT TRANSFERRED ITS DISTRIBUTION OPERATIONS TO
EUROFARMA DISTRIBUIDORA LTDA THEN THE SUBJECT JUST MANUFACTURE AND SALE ITS
PRODUCTS TO EUROFARMA DISTRIBUIDORA LTDA, WHICH RESALE TO THEIR CLIENTS. EUROFARMA IS THE SUBJECT'S TRADING STYLE NAME. IN OCTOBER 04, 2007 THE COMPANY TOOK OVER EUROFARMA COMERCIAL E
IMPORTADORA LTDA. IN OCTOBER 31, 2008 THE COMPANY TOOK OVER EUROFARMA DISTRIBUIDORA
LTDA. LATE 2010 SUBJECT AQUIRED THE COMPANY SEGMENTA LABORATORIOS LTDA,
WHICH HAS BECAME ONE OF SUBJECT'S BRANCHES, NAMED EUROFARMA SEGMENTA. IN MARCH 01, 2011 THE COMPANY TOOK OVER SEGMENTA FARMACÊUTICA LTDA (CNPJ:
45.272.721/0001-99). ON APRIL 01, 2012 SUBJECT TOOK OVER THE COMPANY EMPRESA MOMENTA
FARMACEUTICA LTDA, TAXPAYER NUMBER CNPJ 14.806.008/0001-54, JUCESP/NIRE
35.226.196.797 SHAREHOLDERS /
DIRECTORS: MAURIZIO BILLI: BRAZILIAN, DIVORCED, INDUSTRIAL, HOLDER OF DOCUMENTS
CPF 943.308.168-49 AND RG 6.569.258, RESIDENTIAL ADDRESS AT SÃO PAULO/SP,
WITH OFFICE AT AVENIDA VEREADOR JOSE DINIZ, 3465, CAMPO BELO, ZIP CODE
04603-003, SÃO PAULO/SP; GALLIANO BILLI: ITALIAN, MARRIED, CHEMICAL ENGINEER, HOLDER OF
DOCUMENTS CPF 003.512.538-15 AND RNE W 289981-J, RESIDENTIAL ADDRESS AT SÃO
PAULO/SP, WITH OFFICE AT AVENIDA VEREADOR JOSE DINIZ, 3465, CAMPO BELO, ZIP
CODE 04603-003, SÃO PAULO/SP. MARIA TERESA CASELLI BILLI: NOT AVAILABLE. FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY ARE SO FAR NOT KNOWN. |
|
PUBLIC
INFORMATION: |
|
PROTESTS: |
|
2 PROTESTS,TOTAL AMOUNT R$
3.511,16 |
|
DETAILS OF LATEST PROTESTS: |
|
NOTARY OFFICE: |
DATE: |
VALUE: |
|
CARTÓRIO DE SP-RIBEIRÃO PRETO |
00/11/2011 |
R$ 991,16 |
|
9º CARTÓRIO DE SP-SÃO PAULO |
00/03/2009 |
R$ 2.520,00 |
|
LAWSUITS: |
|
|
|
|
DATE: |
COURT OF LAW: |
|
3 |
EXECUTIVE LAWSUITS |
29/05/12 |
6ª VARA DE SP-SP-CENTRAL |
|
2 |
MUNICIPAL LAWSUITS |
23/03/10 |
1ª VARA DE SP-SÃO BERNARDO DO
CAMPO |
FINANCIAL INFORMATION
|
GENERAL BALANCE SHEETS AS OF 31/12/2011, 31/12/2010 AND 31/12/2009. |
|
( FIGURES ARE IN THOUSANDS OF REAIS ). |
|
ASSETS |
|
|
|
|
CURRENT: |
31/12/2011 |
31/12/2010 |
31/12/2009 |
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS |
4.848 |
17.510 |
40.351 |
|
CLIENTS |
135.679 |
120.611 |
83.874 |
|
INVENTORY |
158.569 |
136.414 |
106.392 |
|
RECOVERABLE TAXES |
75.938 |
10.283 |
32.026 |
|
DEFERRED TAXES |
|
|
13.075 |
|
INVESTMENTS |
|
|
757 |
|
OTHER |
17.028 |
15.305 |
|
|
ACCOUNTS RECEIVABLE |
|
|
3.390 |
|
MARKETABLE SECURITIES |
1.842 |
70.152 |
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT ASSETS |
393.904 |
370.275 |
279.865 |
|
LONG-TERM
RECEIVABLES: |
|
|
|
|
|
|
|
|
|
INTERCOMPANY CREDITS |
253 |
80 |
1.497 |
|
JUDICIAL DEPOSITS |
19.115 |
15.596 |
5.446 |
|
DEFERRED TAXES |
13.918 |
23.345 |
11.245 |
|
RECOVERABLE TAXES |
4.474 |
3.660 |
3.064 |
|
ADVANCE FOR CAPITAL INCREASE |
4.164 |
3.751 |
4.115 |
|
GUARANTEE DEPOSITS |
8.698 |
10.000 |
|
|
OTHER CREDITS |
1.408 |
2 |
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG-TERM RECEIVABLES |
52.030 |
56.434 |
25.367 |
|
FIXED ASSETS: |
|
|
|
|
|
|
|
|
|
INVESTMENTS |
383.109 |
408.649 |
26.258 |
|
FIXED ASSETS |
663.774 |
519.437 |
526.601 |
|
INTANGIBLE |
40.794 |
39.635 |
39.084 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL FIXED ASSETS |
1.087.677 |
967.721 |
591.943 |
|
|
================ |
================ |
================ |
|
TOTAL ASSETS |
1.533.611 |
1.394.430 |
897.175 |
|
LIABILITIES: |
|
|
|
|
CURRENT: |
31/12/2011 |
31/12/2010 |
31/12/2009 |
|
|
|
|
|
|
SUPPLIERS |
43.644 |
38.665 |
11.698 |
|
FOREIGN SUPPLIERS |
|
|
22.719 |
|
LOANS AND FINANCING |
111.380 |
44.729 |
45.542 |
|
SOCIAL / LABOR OBLIGATIONS |
35.343 |
28.438 |
29.372 |
|
TAXES & CONTRIBUTIONS |
11.148 |
7.798 |
18.052 |
|
DEBT WITH RELATED PARTIES |
1.718 |
705 |
4.690 |
|
LEASING |
24.848 |
17.020 |
25.582 |
|
INCOME TAX/SOCIAL CONTRIBUTION |
|
9.446 |
8.024 |
|
PROFIT SHARING |
45.572 |
36.829 |
25.967 |
|
INSTALLMENTS TAXES PAYABLE |
15.217 |
11.155 |
18.288 |
|
ACCOUNTS PAYABLE |
137.663 |
125.925 |
16.121 |
|
INTERESTS ON OWN CAPITAL |
11.583 |
20.847 |
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT LIABILITIES |
438.116 |
341.557 |
226.055 |
|
LONG TERM
LIABILITIES: |
|
|
|
|
|
|
|
|
|
LOANS AND FINANCING |
379.248 |
251.921 |
100.804 |
|
LEASING |
29.144 |
4.979 |
11.598 |
|
OTHER |
1.838 |
1.058 |
5.644 |
|
PROV./LOSSES IN INVESTMENTS |
|
|
17.834 |
|
INSTALLMENTS TAXES PAYABLE |
17.632 |
18.535 |
28.287 |
|
PROVISION FOR CONTINGENCIES |
67.084 |
64.781 |
52.248 |
|
ACCOUNTS PAYABLE |
27.035 |
141.865 |
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG TERM LIABILITIES |
521.981 |
483.139 |
216.415 |
|
NET EQUITY: |
|
|
|
|
|
|
|
|
|
SHARE CAPITAL |
546.813 |
439.790 |
243.425 |
|
ACCRUED PROFIT (LOSS) |
|
132.864 |
211.280 |
|
LEGAL RESERVES |
341 |
|
|
|
PROFIT RESERVES |
23.224 |
|
|
|
OTHER |
3.136 |
-2.920 |
|
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL NET EQUITY |
573.514 |
569.734 |
454.705 |
|
|
================ |
================ |
================ |
|
TOTAL LIABILITIES |
1.533.611 |
1.394.430 |
897.175 |
|
PROFIT AND LOSS ACCOUNTS AS OF 31/12/2011, 31/12/2010 AND 31/12/2009. |
|
( FIGURES ARE IN THOUSANDS OF REAIS ). |
|
|
31/12/2011 |
31/12/2010 |
31/12/2009 |
|
|
|
|
|
|
GROSS SALES |
|
|
1.189.235 |
|
(-) TAXES ON SALES |
|
|
153.953 |
|
|
---------------- |
---------------- |
---------------- |
|
NET SALES |
1.319.073 |
1.165.981 |
1.035.282 |
|
(-) COST OF SOLD GOODS |
396.811 |
294.477 |
262.970 |
|
|
---------------- |
---------------- |
---------------- |
|
GROSS PROFIT |
922.262 |
871.504 |
772.312 |
|
OPERATING REVENUE (EXPENSE) |
-802.092 |
-666.596 |
-567.948 |
|
FINANCIAL REVENUE(EXPENSE) |
-90.118 |
4.758 |
6.550 |
|
|
---------------- |
---------------- |
---------------- |
|
OPERATIONAL PROFIT (LOSS) |
30.052 |
209.666 |
210.914 |
|
CONTRIBUTION/INCOME TAX |
-23.233 |
-55.339 |
-50.678 |
|
|
---------------- |
---------------- |
---------------- |
|
NET PROFIT (LOSS) |
6.819 |
154.327 |
160.236 |
|
RATIOS: |
31/12/2011 |
31/12/2010 |
31/12/2009 |
|
QUICK RATIO |
,54 |
|
,68 |
|
,77 |
|
|
CURRENT RATIO |
,90 |
|
1,08 |
|
1,24 |
|
|
ACCOUNTS RECEIVABLE TURNOVER |
9,72 |
TIMES |
9,67 |
TIMES |
12,34 |
TIMES |
|
DAYS' SALES IN RECEIVABLES |
37,03 |
DAYS |
37,24 |
DAYS |
29,17 |
DAYS |
|
INVENTORY TURNOVER |
2,50 |
TIMES |
2,16 |
TIMES |
2,47 |
TIMES |
|
ACCOUNTS PAYABLE PERIOD |
39,60 |
DAYS |
47,27 |
DAYS |
16,01 |
DAYS |
|
RETURN ON ASSETS |
,86 |
TIMES |
,84 |
TIMES |
1,15 |
TIMES |
|
SALES TURNOVER ON NET EQUITY |
2,30 |
TIMES |
2,05 |
TIMES |
2,28 |
TIMES |
|
NET WORTH TIE-UP |
1,16 |
|
,91 |
|
1,16 |
|
|
INDEBTEDNESS |
1,67 |
|
1,45 |
|
,97 |
|
|
EQUITY RATIO |
37,40 |
% |
40,86 |
% |
50,68 |
% |
|
WORKING CAPITAL RATIO |
-10,09 |
% |
8,41 |
% |
23,80 |
% |
|
GENERAL SOLVENCY |
1,60 |
|
1,69 |
|
2,03 |
|
|
RETURN ON NET EQUITY |
1,19 |
% |
27,09 |
% |
35,24 |
% |
|
RETURN ON SALES (PROFIT MARGIN) |
,52 |
% |
13,24 |
% |
15,48 |
% |
|
GROSS PROFIT MARGIN |
69,92 |
% |
74,74 |
% |
74,60 |
% |
|
OPERATIONAL RESULT |
2,28 |
% |
17,98 |
% |
20,37 |
% |
|
SALES TURNOVER ON LIABILITIES |
3,01 |
TIMES |
3,41 |
TIMES |
4,58 |
TIMES |
|
FOREIGN CURRENCY ON ASSETS |
|
|
|
|
|
|
|
FOREIGN CURRENCY ON LIABILITIES |
|
|
|
|
|
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 2,02 |
- OFFICIAL RATE ON 16/08/2012 |
|
US$ 1,00 = R$ 1,87 |
- OFFICIAL RATE ON 31/12/2011 |
|
US$ 1,00 = R$ 1,66 |
- OFFICIAL RATE ON 31/12/2010 |
|
US$ 1,00 = R$ 1,74 |
- OFFICIAL RATE ON 31/12/2009 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS THE FIGURES AVAILABLE SHOW A SATISFACTORY FINANCIAL STANDING. IT HAS
LOW LIQUIDITY AND HIGH LEVEL OF INDEBTEDNESS. ON THE OTHER HAND, IT SHOWS
HIGH AND GROWING SALES AND POSITIVE RESULT. |
|
REAL ESTATE: |
NOT AVAILABLE
|
VEHICLES: |
NOT AVAILABLE
|
MACHINES: |
NOT AVAILABLE
INSURANCE
|
THE SUBJECT IS SAID TO HOLD INSURANCE POLICIES BUT DETAILS WERE NOT
DISCLOSED. |
BANKING REFERENCES
|
|
BRANCH/PHONE: |
|
|
BANCO ITAU BBA |
2000 |
|
|
BANCO DO BRASIL S/A |
3132-1 |
|
|
BANCO SANTANDER (BRASIL) S/A |
3689 |
|
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE
INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW
PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY
HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682
BRAZILIAN CENTRAL BANK"). |
ACTIVITIES COMMENTS
|
THE SUBJECT IS ENGAGED IN THE MANUFACTURE OF PHARMACEUTICAL PRODUCTS.
IT BELONGS TO BILLI GROUP WHICH IS ALSO OWNER OF COMPANIES ENGAGED IN THE
FIELD OF PHARMACEUTICAL PRODUCTS. THE GROUP HAS 4 DIVISIONS OF BUSINESS: PRODUCTS FOR MEDICAL
PRESCRIPTION, HOSPITAL PRODUCTS, ONCOLOGY PRODUCTS AND OTC PRODUCTS. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
INDIA, CHINA, SPAIN, ITALY, ARGENTINA AND OTHERS. |
EXPORTS TO:
|
URUGUAY, VENEZUELA, COLOMBIA, MEXICO AND OTHERS. |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC
CLIENTS: |
|
PHONE: |
|
AUDIFAR COMERCIAL LTDA |
|
61 361-2101 |
|
DISTRIB MEDICAMENTOS SANTA CRUZ LTDA |
|
11 7087-4022 |
|
DISTRIBUIDORA FARMACÊUTICA PANARELLO LTDA |
|
62 257-7000 |
|
DROGARIA SÃO PAULO LTDA |
|
11 279-8522 |
|
EUROFARMA DISTRIBUIDORA LTDA. |
|
|
|
ITA REPRES DE PRODS FARMACÊUTICOS LTDA |
|
61 361-4363 |
|
MARTINS COM. IMP. EXP LTDA |
|
34 218-1354 |
|
MERCANTIL FARMED LTDA |
|
11 3839-5600 |
|
SAGRA PRODS FARMACÊUTICOS LTDA |
|
16 603-9000 |
|
FOREIGN CLIENTS: |
COUNTRY: |
PHONE: |
|
AMEDRUGS S/A |
URUGUAY |
00598 982-2002 |
|
LAB. GUATIER J.J. CABRERA S/A |
URUGUAY |
00598 2 415454 |
|
MEDIREP S/A |
COSTA RICA |
00506 222-2985 |
|
SERVIMEDIC S/A |
URUGUAY |
00598 2 203-7272 |
|
STAFF: |
|
|
|
THE COMPANY HAS: 3500 EMPLOYEE(S) |
CONCEPT AND FULFILMENT
|
THE SUBJECT IS AN OLD-ESTABLISHED COMPANY, OPERATING SINCE 1962. IT IS
A LEADING COMPANY IN ITS LINE OF BUSINESS AND HAS A VERY IMPORTANT POSITION
IN THE MARKET OF "GENERIC" MEDICINES A KIND OF MEDICINES WIDELY
DIVULGED BY THE GOVERNMENT AND HEALTHY AUTHORITIES IN BRAZIL. THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE
SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS
ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED. MOST OF THE SUPPLIERS WHICH PROVIDED INFORMATION REPORTED PROMPT
PAYMENTS, THUS SHOWING SUBJECT HAS A VERY GOOD PAYMENT BEHAVIOR. THE LAWSUITS REPORTED ARE NOT RELATED WITH TRADE DEBTS. THEY ARE
RELATED TO TAX DEBTS THAT FOR ANY REASON THE COMPANY HAS NOT YET PAID.
NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUITS DO NOT AFFECT THE COMPANY'S
TRADE REPUTATION. THE PROTESTS ARE IRRELEVANT. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC SUPPLIERS: |
|
|
|
ALPAX COM. PROD. P/ LABORATÓRIOS LTDA |
|
|
|
CIA. SIDERÚRGICA NACIONAL |
|
24 344-6808 |
|
ESCALA 7 EDITORA E GRÁFICA LTDA |
|
11 6914-2933 |
|
FORLAB CHITEC S/A |
|
11 3277-0488 |
|
M. CASSAB COMERCIO E INDÚSTRIA LTDA |
|
|
|
ORBIS GRÁFICA LTDA |
|
11 6693-6111 |
|
QUIMINVEST IND E COMERCIO LTDA |
|
|
|
RAI INGREDIENTES AROMAS E FRAGRANCIAS LTDA |
|
|
|
SPRINGER CARRIER LTDA |
|
|
|
VEDAT TAMPAS HERMÉTICAS LTDA |
|
11 4704-4266 |
|
WHEATON DO BRASIL IND. COMERCIO LTDA |
|
11 4351-4433 |
|
FOREIGN
SUPPLIERS: |
COUNTRY: |
|
|
ALMIRAL PRODESFARMA AG |
SWITZERLAND |
|
|
ASTELLAS |
NETHERLANDS |
|
|
GRONINGER & CO. GMBH |
GERMANY |
|
|
INPHARZAM TRADING COMPANY |
LUGANO, SWITZERLAND |
|
|
JUBILANT LIFE SCIENCES LIMITED |
INDIA |
|
|
LABORATOIRE BIODERMA |
FRANCE |
|
|
LABORATORIO PABLO CASSARÁ SRL |
ARGENTINA |
|
|
ORCHID CHEMICALS PHARMACEUTICALS LTD |
INDIA |
|
|
OYSTAR HUTTLIN |
GERMANY |
|
|
SHANGAI PHARMTECH CO. LTD |
CHINA |
|
|
UHLMANN PAC-SYSTEME |
GERMANY |
|
|
PAYMENT HISTORY: |
|
20 SUPPLIERS REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 675.378,00 |
|
|
|
AMOUNT OF INVOICES PAID: 103 |
|
TOTAL OF PROMPT PAYMENTS: 99,1 |
|
TOTAL OF DELAYED PAYMENTS: 0,9% |
|
|
|
HIGHEST INVOICE: R$ 40.731,00 |
|
HIGHEST CREDIT: R$ 40.731,00 |
|
|
|
OUTSTANDING
INVOICES DUE WITHIN THE NEXT 60 DAYS: |
|
--------------------------- |
SUPPLIERS: |
INVOICES: |
TOTAL AMOUNT: |
|
DUE WITHIN 30 DAYS |
3 |
4 |
R$ 16.070,21 |
|
DUE WITHIN 60 DAYS |
1 |
2 |
R$ 5.597,32 |
|
ALL |
3 |
6 |
R$ 21.667,00 |
FINAL OPINION
|
THE SUBJECT IS A TRADITIONAL AND WELL-ESTABLISHED COMPANY IN BUSINESS
SINCE 1962. UP TO DATE IT HAS A CLEAR TRADE HISTORY AND GOOD PAYMENT
BEHAVIOR. IT IS WORTH TO COMMENT THAT THE SUBJECT HAS A LEADING MARKET POSITION
IN A MARKET WHERE IT FACES HIGH COMPETITION FROM FOREIGN COMPANIES FROM
MULTINATIONAL GROUPS OF THE SAME LINE OF BUSINESS. BASED ON THE OVERALL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD
TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN
TERMS AND AMOUNTS ADEQUATE TO THE SUBJECT SCALE OF ACTIVITIES AND FINANCIAL
POWER. |
|
|
|
|
|
|
|
|
|
BALANCE SHEET ANALYSIS |
FIGURES ARE IN THOUSANDS
OF REAIS |
|
|
|
||
|
|
31/12/2011 |
|
31/12/2010 |
|
31/12/2009 |
|
|
ASSETS |
|
% |
|
% |
|
% |
|
Current Assets |
25.68 |
$ 370,275 |
26.55 |
$
279,865 |
31.19 |
|
|
Fixed Assets |
$ 1,087,677 |
70.92 |
$ 967,721 |
69.40 |
$
591,943 |
65.98 |
|
TOTAL ASSETS |
$ 1,533,611 |
100.00 |
$ 1,394,430 |
100.00 |
$
897,175 |
100.00 |
|
LIABILITIES |
|
|
|
|
|
|
|
Current Liabilities |
$ 438,116 |
28.57 |
$ 341,557 |
24.49 |
$
226,055 |
25.20 |
|
Long-Term Liabilities |
$ 521,981 |
34.04 |
$
483,139 |
34.65 |
$
216,415 |
24.12 |
|
TOTAL LIABILITIES |
$ 960,097 |
62.60 |
$ 824,696 |
59.14 |
$
442,470 |
49.32 |
|
Deferred Income |
$ - |
0.00 |
$ - |
0.00 |
$ - |
0.00 |
|
Net Equity |
$ 573,514 |
37.40 |
$ 569,734 |
40.86 |
$
454,705 |
50.68 |
|
TOTAL LIABILITIES + NET EQUITY |
$
1,533,611 |
100.00 |
$ 1,394,430 |
100.00 |
$
897,175 |
100.00 |
|
PROFIT AND LOSS ACCOUNTS |
|
|
|
|
|
|
|
Net Sales |
$ 1,319,073 |
100.00 |
$ 1,165,981 |
100.00 |
$
1,035,282 |
100.00 |
|
Costs |
$ 396,811 |
30.08 |
$ 294,477 |
25.26 |
$
262,970 |
25.40 |
|
Gross Profit |
$ 922,262 |
69.92 |
$ 871,504 |
74.74 |
$
772,312 |
74.60 |
|
Operating expenses |
$ (802,092) |
-60.81 |
$ (666,596) |
-57.17 |
$
(567,948) |
-54.86 |
|
operational Result |
$ 30,052 |
2.28 |
$ 209,666 |
17.98 |
$
210,914 |
20.37 |
|
Net Profit (loss) |
$ 6,819 |
0.52 |
$ 154,327 |
13.24 |
$
160,236 |
15.48 |
|
COMPLEMENTARY DATA |
|
|
|
|
|
|
|
Inventory |
$ 158,569 |
|
$ 136,414 |
|
$
106,392 |
|
|
Accounts receivable |
$ 135,679 |
|
$ 120,611 |
|
$ 83,874 |
|
|
Accounts Payable |
$ 43,644 |
|
$ 38,665 |
|
$ 11,698 |
|
|
Property, plant and equipment |
$ 663,774 |
|
$ 519,437 |
|
$
526,601 |
|
|
Purchases |
$ 1,087,677 |
|
$ 967,721 |
|
$
591,943 |
|
|
Financial Expenses |
$ (90,118) |
|
$ 4,758 |
|
$ 6,550 |
|
|
Foreign Currency Assets |
|
|
|
|
|
|
|
Foreign Currency Liabilities |
|
|
|
|
|
|
|
Working Capital |
$ (44,212) |
|
$ 28,718 |
|
$ 53,810 |
|
|
RATIOS: |
|
|
|
|
|
|
|
QUICK RATIO |
0.54 |
|
0.68 |
|
0.77 |
|
|
CURRENT RATIO |
0.90 |
|
1.08 |
|
1.24 |
|
|
ACCOUNTS RECEIVABLE TURNOVER |
9.72 |
times |
9.67 |
times |
12.34 |
times |
|
DAYS' SALES IN RECEIVABLES |
37.03 |
days |
37.24 |
days |
29.17 |
days |
|
INVENTORY TURNOVER |
2.50 |
times |
2.16 |
times |
2.47 |
times |
|
39.60 |
days |
47.27 |
days |
16.01 |
days |
|
|
RETURN ON ASSETS |
0.86 |
times |
0.84 |
times |
1.15 |
times |
|
SALES TURNOVER ON NET EQUIY |
2.30 |
times |
2.05 |
times |
2.28 |
times |
|
NET WORTH TIE-UP |
1.16 |
|
0.91 |
|
1.16 |
|
|
ENDEBTEDNESS |
1.67 |
|
1.45 |
|
0.97 |
|
|
EQUITY RATIO |
37.40 |
% |
40.86 |
% |
50.68 |
% |
|
WORKING CAPITAL RATIO |
(10.09) |
% |
8.41 |
% |
23.80 |
% |
|
GENERAL SOLVENCY |
1.60 |
|
1.69 |
|
2.03 |
|
|
RETURN ON NET EQUITY |
1.19 |
% |
27.09 |
% |
35.24 |
% |
|
RETURN ON SALES (PROFIT MARGIN) |
0.52 |
% |
13.24 |
% |
15.48 |
% |
|
GROSS PROFIT MARGIN |
69.92 |
% |
74.74 |
% |
74.60 |
% |
|
OPERATIONAL RESULT |
2.28 |
% |
17.98 |
% |
20.37 |
% |
|
SALES TURNOVER ON LIABILITIES |
3.01 |
times |
3.41 |
times |
4.58 |
times |
|
FOREIGN CURRENCY ON ASSETS |
- |
% |
- |
% |
-
|
% |
|
FOREIGN CURRENCY ON LIABILITIES |
- |
% |
- |
% |
- |
% |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.70 |
|
UK Pound |
1 |
Rs.87.55 |
|
Euro |
1 |
Rs.68.85 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.